23 May 2013
Keywords: sanofi, extends, term, immunogen, cancer, accord, usa
Article | 25 September 2006
The USA's ImmunoGen says that the local unit of leading French drugmaker Sanofi-Aventis has exercised its right to extend the ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
25 September 2006
22 May 2013
© 2013 thepharmaletter.com